4.8 Article

Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation

Journal

CELL REPORTS
Volume 14, Issue 4, Pages 907-919

Publisher

CELL PRESS
DOI: 10.1016/j.celrep.2015.12.005

Keywords

-

Categories

Funding

  1. HGSC-BCM: NHGRI [U54 HG003273]
  2. CPRIT grant [RP101353-P7, RPI21018]
  3. Dan L. Duncan Cancer Center NIH P30 Cancer Center [P30 CA125123]
  4. Kavanagh Family Foundation
  5. Australian Pancreatic Cancer Genome Initiative: National Health and Medical Research Council of Australia (NHMRC) [631701, 535903, 427601]
  6. Queensland Government (NIRAP)
  7. University of Queensland
  8. Institute for Molecular Bioscience
  9. Cancer Research UK [C596/A18076, C29717/A17263]
  10. University of Glasgow
  11. Australian Government: Department of Innovation, Industry, Science and Research (DIISR)
  12. Australian Cancer Research Foundation (ACRF)
  13. Cancer Council NSW [SRP06-01, SRP11-01.ICGC]
  14. Cancer Institute NSW [10/ECF/2-26, 06/ECF/1-24, 09/CDF/2-40, 07/CDF/1-03, 10/CRF/1-01, 08/RSA/1-15, 07/CDF/1-28, 10/CDF/2-26, 10/FRL/2-03, 06/RSA/1-05, 09/RIG/1-02, 10/TPG/1-04, 11/REG/1-10, 11/CDF/3-26]
  15. Garvan Institute of Medical Research
  16. Avner Nahmani Pancreatic Cancer Research Foundation
  17. Howat Foundation
  18. R.T. Hall Trust
  19. Petre Foundation
  20. Philip Hemstritch Foundation
  21. Gastroenterological Society of Australia (GESA)
  22. American Association for Cancer Research (AACR) Landon Foundation - INNOVATOR Award
  23. Royal Australasian College of Surgeons (RACS)
  24. Royal Australasian College of Physicians (RACP)
  25. Royal College of Pathologists of Australasia (RCPA)
  26. Italian Ministry of Research [FIRB RBAP10AHJB]
  27. Associazione Italiana Ricerca Cancro [12182]
  28. Fondazione Italiana Malattie Pancreas - Ministero Salute [CUP_J33G13000210001]
  29. Wilhelm Sander Stiftung [2009.039.2]
  30. NIH [P50 CA62924]
  31. Academy of Medical Sciences (AMS) [AMS-SGCL9-Jamieson] Funding Source: researchfish
  32. Cancer Research UK [17263] Funding Source: researchfish
  33. Pancreatic Cancer UK [FLF2015_04_Glasgow] Funding Source: researchfish

Ask authors/readers for more resources

The ampulla of Vater is a complex cellular environment from which adenocarcinomas arise to form a group of histopathologically heterogenous tumors. To evaluate the molecular features of these tumors, 98 ampullary adenocarcinomas were evaluated and compared to 44 distal bile duct and 18 duodenal adenocarcinomas. Genomic analyses revealed mutations in the WNT signaling pathway among half of the patients and in all three adenocarcinomas irrespective of their origin and histological morphology. These tumors were characterized by a high frequency of inactivating mutations of ELF3, a high rate of microsatellite instability, and common focal deletions and amplifications, suggesting common attributes in the molecular pathogenesis are at play in these tumors. The high frequency of WNT pathway activating mutation, coupled with small-molecule inhibitors of beta-catenin in clinical trials, suggests future treatment decisions for these patients may be guided by genomic analysis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available